| Pharmaceutical active ingredients: |
| Mitoxantrone Hydrochloride |
| Available forms, composition and doses of Ralenova: |
| Injectable; Injection; Mitoxantrone Hydrochloride 2 mg / ml |
| Ralenova medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB07 - Mitoxantrone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Wyeth |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Neotalem | Mitoxantrone Hydrochloride | Teva; Chile Laboratorios; Lemery |
| Novantron | Mitoxantrone Hydrochloride | Wyeth; AHP Schweiz; Meda |
| Novantrone | Mitoxantrone Hydrochloride | Wyeth; Dexxon; Immunex; Meda; Neopharm, Israel; Serono; Sigma Pharmaceuticals; Zuellig Pharma |
| Onkotrone | Mitoxantrone Hydrochloride | Baxter; Pliva |
| Pralifan | Mitoxantrone Hydrochloride | Inibsa Laboratorios |
| Refador | Mitoxantrone Hydrochloride | Pliva |
| Santrone | Mitoxantrone Hydrochloride | Korea United Pharmaceutical; HealthCare PharmaScience; Via Hong |
| Preparation CC Cat's Claw | Mitraphylline (Uncaria Tomentosa Bark Extract) | Induquimica Laboratorios |
| Mivacron | Mivacurium Chloride | Abbott; Firma Chun Cheong; GlaxoSmithKline; Hospira; Zuellig Pharma |
| Mivacron in Dextrose 5% in plastic container | Mivacurium Chloride | Abbott |